mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases

Paula Cilleros-Holgado1, David Gómez-Fernández1, Rocío Piñero-Pérez1

  • 1Centro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), 41013 Sevilla, Spain.

Insights

Modulating the mitochondrial unfolded protein response (mtUPR) offers a promising therapeutic strategy for mitochondrial dysfunction, improving cell health in various diseases. However, caution is advised due to potential risks in cancer and side effects from overactivation.

Area of Science:

  • Mitochondrial Biology
  • Cellular Stress Responses
  • Therapeutic Strategies

Background:

  • Mitochondrial dysfunction is central to numerous diseases, impacting energy production, calcium balance, apoptosis, and reactive oxygen species (ROS).
  • Current treatments for primary and secondary mitochondrial diseases remain limited.
  • The mitochondrial unfolded protein response (mtUPR) represents a novel therapeutic avenue.

Purpose of the Study:

  • To review current data on mtUPR modulation as a therapeutic approach.
  • To explore the role of mtUPR in various diseases.
  • To discuss potential negative consequences of mtUPR activation.

Main Methods:

  • Review of recent scientific literature on mtUPR.
  • Analysis of mtUPR's role in cellular homeostasis and disease models.
  • Evaluation of therapeutic potential and risks associated with mtUPR modulation.

Main Results:

  • mtUPR activation promotes cell homeostasis and improves outcomes in models of mitochondrial dysfunction, age-related diseases, cardiopathies, metabolic disorders, and primary mitochondrial diseases.
  • mtUPR activation may paradoxically promote tumor progression in cancer.
  • Overactivation of mtUPR can lead to adverse effects, including increased mitochondrial DNA (mtDNA) heteroplasmy.

Conclusions:

  • mtUPR modulation is a promising therapeutic strategy for mitochondrial dysfunction-related conditions.
  • Careful consideration of mtUPR's dual role in disease and potential side effects is crucial for its clinical application.
  • Further research is needed to optimize mtUPR-based therapies and mitigate risks.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.8K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.9K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
2.6K